Study of VIR-2482 in Healthy Volunteers
Study of VIR-2482 in Healthy Volunteers
This is a phase 1/2 study in which healthy volunteers will receive VIR-2482 or placebo and
 will be assessed for safety, pharmacokinetics, immunogenicity, and efficacy of VIR-2482 in
 preventing Influenza A illness.
Inclusion Criteria:

 -  Healthy Male or Female age 18 to < 65 years

 -  Body mass index (BMI) of 18.0 kg/m^2 to 35.0kg/m^2

 Exclusion Criteria:

 -  Any prior or planned influenza vaccination for the upcoming flu season

 -  Any clinically significant chronic or acute medical condition that makes the volunteer
 unsuitable for participation

 -  History of influenza-like illness or confirmed influenza infection within 3 months
 prior to randomization.

 -  Fever-like illness within 5 days of randomization.

 -  History or clinical evidence of conditions considered high risk for developing
 influenza-related complications.